1. Home
  2. NBIX vs HTHT Comparison

NBIX vs HTHT Comparison

Compare NBIX & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$174.19

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo H World Group Limited

HTHT

H World Group Limited

HOLD

Current Price

$41.91

Market Cap

13.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
HTHT
Founded
1992
2005
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.6B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
NBIX
HTHT
Price
$174.19
$41.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
4
Target Price
$180.91
$56.60
AVG Volume (30 Days)
1.1M
2.0M
Earning Date
05-05-2026
05-19-2026
Dividend Yield
N/A
4.07%
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$7.18
Revenue Next Year
$13.14
$6.71
P/E Ratio
$91.24
$30.34
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$30.42
52 Week High
$174.38
$56.53

Technical Indicators

Market Signals
Indicator
NBIX
HTHT
Relative Strength Index (RSI) 67.99 39.70
Support Level $153.96 $41.53
Resistance Level N/A $45.65
Average True Range (ATR) 4.48 1.27
MACD 0.66 0.08
Stochastic Oscillator 95.56 28.23

Price Performance

Historical Comparison
NBIX
HTHT

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About HTHT H World Group Limited

H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.

Share on Social Networks: